标题
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19
作者
关键词
COVID-19, SARS-CoV-2, Pandemic, Peptides-based therapeutics, S protein-hACE2 interaction, In silico, method
出版物
THERAPIE
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-10-09
DOI
10.1016/j.therap.2021.09.007
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
- (2020) Shuai Xia et al. Cellular & Molecular Immunology
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
- (2020) Yanxiao Han et al. ACS Nano
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
- (2020) Qihui Wang et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis
- (2020) Ju Kim et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity
- (2020) Yuanmei Zhu et al. JOURNAL OF VIROLOGY
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
- (2020) Catrin Sohrabi et al. International Journal of Surgery
- De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2
- (2020) Xiaoqiang Huang et al. Aging-US
- Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
- (2020) Effat Davoudi-Monfared et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical trials of repurposed antivirals for SARS-CoV-2
- (2020) Miguel Angel Martinez ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Snake venom‐derived bradykinin‐potentiating peptides: A promising therapy for COVID ‐19?
- (2020) Ahmed S. Gouda et al. DRUG DEVELOPMENT RESEARCH
- Clinical trials for the prevention and treatment of COVID ‐19: current state of play
- (2020) Joshua S Davis et al. MEDICAL JOURNAL OF AUSTRALIA
- In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
- (2020) Rongsong Ling et al. PEPTIDES
- Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells
- (2020) Mirza S. Baig et al. DRUGS IN R&D
- Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches
- (2020) Rong Dong et al. Frontiers in Immunology
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2
- (2020) Hanjun Zhao et al. Nature Communications
- Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2
- (2020) Lili Wu et al. Cell Discovery
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
- (2019) Shuai Xia et al. Science Advances
- Human Antimicrobial Peptides as Therapeutics for Viral Infections
- (2019) Aslaa Ahmed et al. Viruses-Basel
- Cell penetrating peptides: the potent multi-cargo intracellular carriers
- (2019) Kimia Kardani et al. Expert Opinion on Drug Delivery
- The human coronavirus HCoV‐229E S‐protein structure and receptor binding
- (2019) Zhijie Li et al. eLife
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Peptide chemistry toolbox – Transforming natural peptides into peptide therapeutics
- (2018) Miloš Erak et al. BIOORGANIC & MEDICINAL CHEMISTRY
- HPEPDOCK: a web server for blind peptide–protein docking based on a hierarchical algorithm
- (2018) Pei Zhou et al. NUCLEIC ACIDS RESEARCH
- Antimicrobial Peptides
- (2018) Donald E. Fry Surgical Infections
- Recombinant Interferons Beta-1a and Beta-1b: Protein Structural Features and Problematic Issues with Identity Confirmation
- (2018) E. O. Goloshchapova et al. PHARMACEUTICAL CHEMISTRY JOURNAL
- Defensins in Viral Infection and Pathogenesis
- (2017) Mayumi K. Holly et al. Annual Review of Virology
- Pre-fusion structure of a human coronavirus spike protein
- (2016) Robert N. Kirchdoerfer et al. NATURE
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- APD3: the antimicrobial peptide database as a tool for research and education
- (2015) Guangshun Wang et al. NUCLEIC ACIDS RESEARCH
- Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
- (2015) Guangwen Lu et al. TRENDS IN MICROBIOLOGY
- CancerPPD: a database of anticancer peptides and proteins
- (2014) Atul Tyagi et al. NUCLEIC ACIDS RESEARCH
- AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses
- (2013) Abid Qureshi et al. NUCLEIC ACIDS RESEARCH
- AVPpred: collection and prediction of highly effective antiviral peptides
- (2012) Nishant Thakur et al. NUCLEIC ACIDS RESEARCH
- Antimicrobial peptides important in innate immunity
- (2011) Andreas Cederlund et al. FEBS Journal
- Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
- (2011) Jianshe Lang et al. PLoS One
- Recently Discovered Human Coronaviruses
- (2009) Brigitte A. Wevers et al. CLINICS IN LABORATORY MEDICINE
- Argininosuccinate Synthetase Is a Functional Target for a Snake Venom Anti-hypertensive Peptide
- (2009) Juliano R. Guerreiro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary Disease
- (2009) C. L. Wohlford-Lenane et al. JOURNAL OF VIROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started